Report of Foreign Issuer (6-k)

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
______________________

FORM 6-K

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For January 20, 2016

______________________

ASML Holding N.V.

De Run 6501

5504 DR Veldhoven

The Netherlands

(Address of principal executive offices)

______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

EXHIBITS 99.1, 99.3, AND 99.4 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-142254), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-162439), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-170034), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-188938), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-190023), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-192951) AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-203390) OF ASML HOLDING N.V. AND IN THE OUTSTANDING PROSPECTUSES CONTAINED IN SUCH REGISTRATION STATEMENTS.

Exhibits


99.1	“ASML reports record sales for 2015. Proposes to raise dividend by 50% and announces plan for additional EUR 1 billion share repurchases”, press release dated January 20, 2016


99.2	“ASML reports record sales for 2015. Proposes to raise dividend by 50%. Announces plan for additional € 1 billion share repurchases”, presentation dated January 20, 2016


99.3	Summary U.S. GAAP Consolidated Financial Statements

99.4 Summary IFRS Consolidated Financial Statements

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ASML HOLDING N.V. (Registrant)

Date: January 20, 2016 By: /s/ Peter T.F.M. Wennink

Peter T.F.M. Wennink

Chief Executive Officer

Exhibit 99.1

Media Relations Contacts

Lucas van Grinsven - Corporate Communications - +31 6 101 99 532 - Veldhoven, the Netherlands

Niclas Mika - Corporate Communications - +31 6 201 528 63 - Veldhoven, the Netherlands

Investor Relations Contacts

Craig DeYoung - Investor Relations - +1 480 696 2762 - Chandler, Arizona, USA

Marcel Kemp - Investor Relations - +31 40 268 6494 - Veldhoven, the Netherlands

ASML reports record sales for 2015

Proposes to raise dividend by 50% and announces plan for additional EUR 1 billion share repurchases

VELDHOVEN, the Netherlands, January 20, 2016 - ASML Holding N.V. (ASML) today publishes its 2015 fourth-quarter and full-year results.


•	Full-year 2015 sales were a record EUR 6.3 billion with a gross margin of 46.1 percent


•	Q4 net sales of EUR 1.43 billion, gross margin 46.0 percent


•	ASML proposes dividend of EUR 1.05 per share and announces plan for additional share repurchases of EUR 1 billion in 2016-2017


•	ASML guides Q1 2016 net sales at approximately EUR 1.3 billion and a gross margin of around 42 percent



(Figures in millions of euros unless otherwise indicated)	Q3 2015	Q4 2015	FY 2014	FY 2015
Net sales	1,549	1,434	5,856	6,287
...of which service and field option sales	574	553	1,613	2,050

Other income (Co-Investment Program)	21	21	81	83

New systems sold (units)	39	32	116	144
Used systems sold (units)	5	5	20	25
Average Selling Price (ASP) of net system sales	22.2	23.8	31.2	25.1

Net bookings*	904	1,184	4,902	4,639
Systems backlog*	2,880	3,184	2,772	3,184

Gross profit	703	660	2,596	2,896
Gross margin (%)	45.4	46.0	44.3	46.1

Net income	322	292	1,197	1,387
EPS (basic; in euros)	0.75	0.68	2.74	3.22

End-quarter cash and cash equivalents and short-term investments	2,681	3,409	2,754	3,409

*) For the adjusted definition of our net bookings and systems backlog see footnote 4 of our US GAAP Consolidated Financial Statements.

A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com

CEO Statement

"Our full-year 2015 net sales marked a new record at EUR 6.3 billion, up from EUR 5.9 billion in 2014, including service and field option sales that rose to a record EUR 2 billion. We expect 2016 first-quarter sales at approximately EUR 1.3 billion. As we indicated three months ago, we expect our logic customers to take shipments of our leading edge immersion tools in the second quarter in preparation of their 10 nanometer node ramp. As a result, we expect second-quarter sales to increase significantly from the first-quarter level," ASML President and Chief Executive Officer Peter Wennink said.

Product and Business Highlights


•	In Deep-Ultraviolet (DUV) lithography, we began ramping shipments of the TWINSCAN NXT:1980, our most advanced immersion system, in the fourth quarter, shipping five systems. The installation of the first systems is complete.


•	In Holistic Lithography, which grew by over 20 percent in revenue in 2015, we saw increased adoption of our latest metrology systems and control software at both logic

and memory customers. These applications play a more and more critical role in helping our customers achieve the best possible patterning performance on advanced nodes.

•

Extreme Ultraviolet (EUV) lithography met its 2015 productivity and availability targets. We had already achieved a productivity of more than 1,000 wafers per day early in 2015 on the NXE:3300B system and improved this to more than 1,250 wafers per day in the fourth quarter on the successor system, the NXE:3350B. In addition, the availability of systems in the field improved, with the majority of systems achieving a four-week availability of more than 70 percent in recent months; the best result was more than 80 percent over four weeks. We also shipped two of our latest NXE:3350B EUV systems and started shipping the third in 2015. They will be used in our customers' fabs for preparing the introduction of EUV into volume production. Our goals for 2016 are to continue improving productivity and availability and shipping six to seven EUV systems.

Outlook

For the first-quarter of 2016, ASML expects net sales at approximately EUR 1.3 billion, a gross margin of around 42%, R&D costs of about EUR 275 million, other income of about EUR 23 million -- which consists of contributions from participants of the Customer Co-Investment Program --, SG&A costs of about EUR 90 million and an effective annualized tax rate of around 13%.

Dividend and new Share Buyback Program

In accordance with its financial policy, ASML intends to continue to return excess cash to shareholders on a regular basis through stable or growing dividends and share buyback programs.

Supported by its long term business plan, ASML proposes a dividend per ordinary share which is 50 percent higher compared with last year. Therefore, we will submit a proposal to the 2016 Annual General Meeting of Shareholders (AGM) to declare a dividend in respect of 2015 of EUR 1.05 per ordinary share (for a total amount of approximately EUR 450 million), compared with a dividend of EUR 0.70 per ordinary share paid in respect of 2014.

ASML also announces a new share buyback program, to be executed within the 2016-2017 time frame. As part of this program, ASML intends to purchase shares up to EUR 1.5 billion, which includes an amount of approximately EUR 500 million remaining from the prior

program, announced on January 21, 2015. ASML intends to cancel the shares upon repurchase. This buyback program will start on January 21, 2016.

The share buyback program will be executed within the limitations of the existing authority granted by the AGM on April 22, 2015 and of the authority granted by future AGMs. The share buyback program may be suspended, modified or discontinued at any time. All transactions under this program will be published on ASML's website (www.asml.com/investors) on a weekly basis.

About ASML

ASML is one of the world’s leading manufacturers of chip-making equipment. Our vision is to enable affordable microelectronics that improve the quality of life. To achieve this, our mission is to invent and develop advanced technology for high-tech lithography, metrology and software solutions for the semiconductor industry. ASML's guiding principle is continuing Moore's Law towards ever smaller, cheaper, more powerful and energy-efficient semiconductors. This results in increasingly powerful and capable electronics that enable the world to progress within a multitude of fields, including healthcare, technology, communications, energy, mobility, and entertainment. We are a multinational company with over 70 locations in 16 countries, headquartered in Veldhoven, the Netherlands.We employ more than 14,000 people on payroll and flexible contracts (expressed in full time equivalents). ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. More information about ASML, our products and technology, and career opportunities is available on: www.asml.com

Press conference

A press conference hosted by CEO Peter Wennink and CFO Wolfgang Nickl will be held at our office in Veldhoven at 11:00 AM Central European Time / 05:00 AM U.S. Eastern time. An audio webcast of the press conference is available on www.asml.com.

Investor and Media Conference Call

A conference call for investors and media will be hosted by CEO Peter Wennink and CFO Wolfgang Nickl at 15:00 PM Central European Time / 09:00 AM U.S. Eastern time. To register for the call and receive dial-in information, go to www.asml.com/qresultscall. Listen-only access is also available via www.asml.com.

2015 Annual Reports

ASML will publish its 2015 Annual Report on Form 20-F, Statutory Annual Report, Corporate Responsibility Report and Remuneration Report on February 5, 2016. The reports will be published on our website at www.asml.com.

US GAAP and IFRS Financial Reporting

ASML's primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States of America. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows and consolidated balance sheets, and a reconciliation of net income and equity from US GAAP to IFRS as adopted by the EU (‘IFRS’) are available on www.asml.com

In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of share-based payment plans and the accounting of income taxes. ASML’s quarterly IFRS consolidated statement of profit or loss, consolidated statement of cash flows, consolidated statement of financial position and a reconciliation of net income and equity from US GAAP to IFRS are available on www.asml.com

The consolidated balance sheets of ASML Holding N.V. as of December 31, 2015, the related consolidated statements of operations and consolidated statements of cash flows for the quarter and year ended December 31, 2015 as presented in this press release are unaudited.

Regulated Information

This press release constitutes regulated information within the meaning of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).

Forward Looking Statements

This document contains statements relating to certain projections and business trends that are forward-looking, including statements with respect to our outlook, including expected customer demand in specified market segments including memory, logic and foundry, expected trends, expected liquidity and capital structure, expected levels of service sales, systems backlog, expected financial results for the first quarter of 2016 and expected sales trends in the second quarter, including expected sales, other income, gross margin, R&D and SG&A expenses and effective tax rate, annual revenue opportunity for ASML and EPS potential by end of decade, productivity of our tools and systems performance, TWINSCAN and EUV system performance (such as endurance tests), expected industry trends, statements with respect to expected system shipments, including the number of EUV systems expected to be shipped and timing of shipments and recognition in revenue and other EUV targets (including availability, productivity and shipments) and roadmaps, shrink being key driver to industry growth, the expected continuation of Moore's law and that EUV will continue to enable Moore’s law and drive long term value, goals for holistic lithography, intention to return excess cash to shareholders, and statements about our proposed dividend, dividend policy and intention to repurchase shares. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about the business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of general economic conditions on consumer confidence and demand for our customers' products, competitive products and pricing, the impact of manufacturing efficiencies and capacity constraints, performance of our systems, the continuing success of technology advances and the related pace of new product development and customer acceptance of new products, the number and timing of EUV systems expected to be shipped and recognized in revenue, delays in EUV systems production and development, our ability to enforce patents and protect intellectual property rights, the risk of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates, changes in tax rates, available cash and liquidity, our ability to refinance our indebtedness, distributable reserves for dividend payments and share repurchases, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

ASML reports record sales for 2015 Proposes to raise dividend by 50% Announces plan for additional €1 billion share repurchases ASML 2015 Fourth-Quarter and 2015 Annual Results Veldhoven, the Netherlands January 20, 2016 Public

Public Slide 2 January 20, 2016 This document contains statements relating to certain projections and business trends that are forward-looking, including statements with respect to our outlook, including expected customer demand in specified market segments including memory, logic and foundry, expected trends, expected liquidity and capital structure, expected levels of service sales, systems backlog, expected financial results for the first quarter of 2016 and expected sales trends in the second quarter, including expected sales, other income, gross margin, R&D and SG&A expenses and effective tax rate, annual revenue opportunity for ASML and EPS potential by end of decade, productivity of our tools and systems performance, TWINSCAN and EUV system performance (such as endurance tests), expected industry trends, statements with respect to expected system shipments, including the number of EUV systems expected to be shipped and timing of shipments and recognition in revenue and other EUV targets (including availability, productivity and shipments) and roadmaps, shrink being key driver to industry growth, the expected continuation of Moore's law and that EUV will continue to enable Moore’s law and drive long term value, goals for holistic lithography, intention to return excess cash to shareholders, and statements about our proposed dividend, dividend policy and intention to repurchase shares. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about the business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of general economic conditions on consumer confidence and demand for our customers' products, competitive products and pricing, the impact of manufacturing efficiencies and capacity constraints, performance of our systems, the continuing success of technology advances and the related pace of new product development and customer acceptance of new products, the number and timing of EUV systems expected to be shipped and recognized in revenue, delays in EUV systems production and development, our ability to enforce patents and protect intellectual property rights, the risk of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates, changes in tax rates, available cash and liquidity, our ability to refinance our indebtedness, distributable reserves for dividend payments and share repurchases, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. These forward- looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward looking statements

Public Slide 3 January 20, 2016 Agenda • Investor key messages • Business highlights • Business environment • Outlook • EUV highlights • Financial statements

Public Slide 4 January 20, 2016 Investor key messages

Public Slide 5 January 20, 2016 Investor key messages • Shrink is the key industry driver supporting innovation and providing long term industry growth • Moore’s Law will continue and be affordable • Lithography enables affordable shrink and therefore delivers compelling value for our customers • ASML’s strategy of large R&D investments in lithography product roadmaps supports future industry needs • DUV product improvement roadmaps and Holistic Litho enable multi-pass immersion patterning today, with Holistic Litho supporting EUV in future. These highly differentiated products provide unique value drivers for us and our customers • EUV faces normal new technology introduction challenges but its adoption is now a matter of WHEN not IF. EUV will continue to enable Moore’s Law and will drive long term value for ASML • ASML models an annual revenue opportunity of €10 billion by 2020 and given the significant leverage in our financial model this will allow a potential tripling of EPS by the end of this decade, compared to calendar year 2014, thereby creating significant value for all stakeholders • We expect to continue to return excess cash to our shareholders through dividends that are stable or growing and regularly timed share buybacks in line with our policy

Public Slide 6 January 20, 2016 Business highlights

Public Slide 7 January 20, 2016 2015 - highlights • Record net sales of € 6.3 billion, including record Service and Options sales of € 2 billion, gross margin 46.1%, net income € 1.4 billion and EPS € 3.22 • EUV: we met our 2015 productivity and availability targets and successfully started shipping NXE:3350B, our 4th generation EUV system • DUV: successful ramping our TWINSCAN NXT:1980, our next generation immersion system, shipped 7 systems • Holistic litho: continued adoption of these products with all our major customers • Capital return: returned € 867 million cash to shareholders through combined dividend and share buyback

Public Slide 8 January 20, 2016 Q4 results summary • Q4 sales in line with our guidance • Net sales of € 1,434 million, 37 litho systems sold, valued at € 881 million, net service and field option sales at € 553 million • Average selling price of € 23.8 million per system • Gross margin of 46.0% • Operating margin of 22.2% • Net bookings of € 1,184 million • Backlog at € 3,184 million Numbers have been rounded for readers’ convenience

Public Slide 9 January 20, 2016 EUV ArF i ArFdry KrF I-Line — 14 2 24 4 Net system sales breakdown in value Technology ArF Immersion 72% ArF Dry 3% KrF 23% I-line 2% Region (ship to location) USA 13% Korea 36% Taiwan 31% China 10% Japan 9% Europe 1% End-Use Memory 44% Foundry 44%IDM 12% Q4’15 total value € 881 million Sales in Units EUV ArF i ArFdry KrF I-Line — 11 3 20 3 Q3’15 total value € 975 million ArF Immersion 68% ArF Dry 3% KrF 27% I-line 2% Memory 56% Foundry 32% IDM 12% Numbers have been rounded for readers’ convenience USA 15% Korea 28% Taiwan 30% China 14% Japan 11% Rest of Asia 2%

Public Slide 10 January 20, 2016 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 N et Sa le s 2010 2011 2012 2013 2014 2015 742 1,452 1,252 892 1,397 1,650 1,069 1,529 1,228 1,187 1,644 1,6541,176 1,459 1,229 1,318 1,322 1,549 1,521 4,508 1,211 5,651 1,023 4,732 1,848 5,245 1,494 1,434 Total net sales million € by quarter Q4 Q3 Q2 Q1 5,856 Numbers have been rounded for readers’ convenience 6,287

Public Slide 11 January 20, 2016 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 N et Sa le s 2010 2011 2012 2013 2014 2015 2,585 2,184 935 1,489 2,225 2,115 366 844 588 440 831 514 944 1,856 2,279 2,064 1,186 1,608 613 4,508 767 5,651 930 4,732 1,252 5,245 1,614 5,856 2,050 Total net sales million € by End-use 6,287 Service & Options Foundry IDM Memory Numbers have been rounded for readers’ convenience

Public Slide 12 January 20, 2016 Bookings activity by sector As of Q2 2015, our systems backlog and net bookings include all system sales orders for which written authorizations have been accepted (for EUV starting as of the NXE:3350B) Q4’15 total value € 1,184 million New systems Used systems Units 39 5 Value M€ 1,174 10 New systems Used systems Units 32 3 Value M€ 899 5 Q3’15 total value € 904 million Memory 47% Foundry 52% IDM 1% Memory 52% Foundry 38%IDM10% Numbers have been rounded for readers’ convenience

Public Slide 13 January 20, 2016 System backlog in value Backlog definition see slide 12 Technology EUV 23% ArF Immersion 61% ArF Dry 5% KrF 10% I-line 1% Region (ship to location) USA 34% Korea 29% Taiwan 16% China 16% Japan 1% Rest of Asia 3% Europe 1% End-Use Memory 31% Foundry 37% IDM 32% Q4’15 total value € 3,184 million Q3’15 total value € 2,880 million EUV 26% ArF Immersion 59% ArF Dry 3% KrF 11% I-line 1% Memory 33% Foundry 29% IDM 38% USA 39% Korea 36% Taiwan 16% China 3% Japan 4% Europe 2% New systems Used systems Units 68 11 Value M€ 3,149 35 New systems Used systems Units 61 11 Value M€ 2,835 45 Numbers have been rounded for readers’ convenience

Public Slide 14 January 20, 2016 Capital return to shareholders • Paid € 302 million in dividend and purchased € 565 million worth of our own shares in 2015 • Propose to increase dividend by 50% to € 1.05 per ordinary share • Announcing new plan for share buyback program of € 1.5 billion over 2016/2017, which includes approx. € 500 million remaining of our prior program Dividend history 1.2 1.0 0.8 0.6 0.4 0.2 0.0 D iv id en d (e ur o) 2007 2008 2009 2010 2011 2012 2013 2014 2015 0.25 0.20 0.20 0.40 0.46 0.53 0.61 0.70 1.05 Cumulative capital return 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 € m illi on 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Dividend Share buyback The dividend for a year is paid in the subsequent year Numbers have been rounded for readers’ convenience proposed

Public Slide 15 January 20, 2016 Business environment

Public Slide 16 January 20, 2016 • 2x nm DRAM node progressing, 1x nm node initial production starting • Planar NAND shrink continues • 3D NAND technology ramping • New fab announcement for China • One fab near completion and one fab equipment-ready by mid year • X-Point architecture introduced and market opportunity being evaluated • Multiple new foundry fabs accepting equipment in 2016 • Continued demand for litho tools for several nodes • Modest tool shipments continue for 28 nm and 16/14 nm nodes • 10 nm foundry and MPU significant volume ramp starting in Q2 2016 • High demand for service and field options continues to be driven by Holistic litho, growing installed base and upgrade products which allows for improved process control and capital efficiency Business environment Service & field options Memory Logic

Public Slide 17 January 20, 2016 Outlook

Public Slide 18 January 20, 2016 Outlook • Q1 net sales approximately € 1.3 billion • Gross margin around 42% • R&D costs of about € 275 million • SG&A costs of about € 90 million • Other income (Customer Co-Investment Program) of about € 23 million • Effective tax rate for full year 2016 around 13% • Our guidance for Q1: Numbers have been rounded for readers’ convenience • As we indicated 3 months ago, we expect logic customers to take shipments for ramping the 10 nm node starting Q2 • As a result, we expect Q2 sales to increase significantly from Q1 level

Public Slide 19 January 20, 2016 EUV highlights

Public Slide 20 January 20, 2016 EUV targets and achievements • More than 1000 wafers per day exposed on NXE:3300B at customer site, further improved to more than 1250 wafers per day on NXE:3350B at ASML • More than 15,000 wafers exposed in four-week manufacturing readiness test at customer site • Majority of customer systems achieved four-week average availability of more than 70%; best result more than 80% over four weeks • Overall annual average availability is lower, still needs to be improved • Two NXE:3350B systems shipped as of end-2015 • One shipment in progress Productivity - Target: 1000 wafers per day Availability - Target: 70% NXE:3350 - Target: 6 1500 wafers per day 80% 6-7 NXE shipments (NXE:3300, NXE:3350, NXE:3400) 2016 targets2015 achievements

Public Slide 21 January 20, 2016 Financial statements

Public Slide 22 January 20, 2016 Consolidated statements of operations M€ Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Net sales 1,494 1,650 1,654 1,549 1,434 Gross profit 657 779 754 703 660 Gross margin % 44.0% 47.2% 45.6% 45.4% 46.0% Other income* 20 21 21 21 21 R&D costs (268) (261) (267) (267) (273) SG&A costs (79) (82) (88) (86) (90) Income from operations 330 456 419 372 318 Operating income % 22.1% 27.6% 25.3% 24.0% 22.2% Net income 305 403 370 322 292 Net income as a % of net sales 20.4% 24.4% 22.4% 20.8% 20.4% Earnings per share (basic) € 0.70 0.93 0.86 0.75 0.68 Earnings per share (diluted) € 0.70 0.93 0.85 0.75 0.68 Litho units sold 35 47 41 44 37 ASP new litho systems 34.7 30.8 32.5 24.2 26.9 Net booking value** 1,387 1,028 1,523 904 1,184 * Customer Co-Investment Program (CCIP) ** As of Q2 2015, our systems backlog and net bookings include all system sales orders for which written authorizations have been accepted (for EUV starting as of the NXE:3350B). This change has no impact on the comparative figures. Numbers have been rounded for readers’ convenience

Public Slide 23 January 20, 2016 Cash flows M€ Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Net income 305 403 370 322 292 Net cash provided by (used in) operating activities 409 337 284 420 985 Net cash provided by (used in) investing activities 77 124 (107) (99) (1,078) Net cash provided by (used in) financing activities (213) (112) (458) (133) (131) Net increase (decrease) in cash & cash equivalents 275 359 (284) 186 (222) Free cash flow* 281 250 205 333 864 * Free cash flow is defined as net cash provided by (used in) operating activities minus investments in Capex (Purchase of Property, plant and equipment and intangibles), see US GAAP Consolidated Financial Statements Numbers have been rounded for readers’ convenience

Public Slide 24 January 20, 2016 Balance sheets M€ Assets Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Cash & cash equivalents and short-term investments 2,754 2,838 2,520 2,681 3,409 Net accounts receivable and finance receivables 1,304 1,510 1,589 1,593 1,208 Inventories, net 2,550 2,607 2,592 2,537 2,574 Other assets 835 929 871 846 940 Tax assets 232 299 264 203 181 Goodwill 2,358 2,611 2,569 2,574 2,624 Other intangible assets 724 774 751 739 738 Property, plant and equipment 1,447 1,523 1,519 1,533 1,621 Total assets 12,204 13,091 12,675 12,706 13,295 Liabilities and shareholders' equity Current liabilities 2,889 3,194 2,854 2,711 3,107 Non-current liabilities 1,802 1,820 1,859 1,850 1,799 Shareholders' equity 7,513 8,077 7,962 8,145 8,389 Total liabilities and shareholders' equity 12,204 13,091 12,675 12,706 13,295 Numbers have been rounded for readers’ convenience

Exhibit 99.3

ASML - Summary US GAAP Consolidated Statements of Operations ^1,2



		Three months ended,				Twelve months ended,
		Dec 31,		Dec 31,		Dec 31,		Dec 31,
		2014		2015		2014		2015
(in millions EUR, except per share data)

Net system sales		1,085.3		880.9		4,242.8		4,237.2
Net service and field option sales		408.7		553.3		1,613.5		2,050.2
Total net sales		1,494.0		1,434.2		5,856.3		6,287.4

Total cost of sales		(837.1	)	(774.4	)	(3,259.9	)	(3,391.7	)
Gross profit		656.9		659.8		2,596.4		2,895.7

Other income		20.2		20.8		81.0		83.2
Research and development costs		(268.0	)	(273.0	)	(1,074.1	)	(1,068.1	)
Selling, general and administrative costs		(79.4	)	(89.5	)	(321.1	)	(345.7	)
Income from operations		329.7		318.1		1,282.2		1,565.1

Interest and other, net		(2.6	)	(4.6	)	(8.6	)	(16.5	)
Income before income taxes		327.1		313.5		1,273.6		1,548.6

Benefit from (provision for) income taxes		(22.3	)	(21.1	)	(77.0	)	(161.4	)
Net income		304.8		292.4		1,196.6		1,387.2


Basic net income per ordinary share		0.70		0.68		2.74		3.22
Diluted net income per ordinary share	³	0.70		0.68		2.72		3.21


Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic		434.1		428.8		437.1		430.6
Diluted	³	436.7		430.8		439.7		432.6

ASML - Ratios and Other Data ^1,2



	Three months ended,					Twelve months ended,
	Dec 31,		Dec 31,			Dec 31,		Dec 31,
	2014		2015			2014		2015
(in millions EUR, except otherwise indicated)

Gross profit as a percentage of net sales	44.0	%	46.0	%		44.3	%	46.1	%
Income from operations as a percentage of net sales	22.1	%	22.2	%		21.9	%	24.9	%
Net income as a percentage of net sales	20.4	%	20.4	%		20.4	%	22.1	%
Income taxes as a percentage of income before income taxes	6.8	%	6.7	%		6.0	%	10.4	%
Shareholders’ equity as a percentage of total assets	61.6	%	63.1	%		61.6	%	63.1	%
Sales of systems (in units)	35		37			136		169
Average selling price of system sales (EUR millions)	31.0		23.8			31.2		25.1
Value of systems backlog (EUR millions)	2,772		3,184		⁴	2,772		3,184		⁴
Systems backlog (in units)	82		79		⁴	82		79		⁴
Average selling price of systems backlog (EUR millions)	33.8		40.3		⁴	33.8		40.3		⁴
Value of booked systems (EUR millions)	1,387		1,184		⁴	4,902		4,639		⁴
Net bookings (in units)	51		44		⁴	157		165		⁴
Average selling price of booked systems (EUR millions)	27.2		26.9		⁴	31.2		28.1		⁴
Number of payroll employees in FTEs	11,318		12,168			11,318		12,168
Number of temporary employees in FTEs	2,754		2,513			2,754		2,513

ASML - Summary US GAAP Consolidated Balance Sheets^1,2



	Dec 31,	Dec 31,
	2014	2015
(in millions EUR)

ASSETS
Cash and cash equivalents	2,419.5	2,458.7
Short-term investments	334.9	950.0
Accounts receivable, net	1,052.5	803.7
Finance receivables, net	196.1	280.5
Current tax assets	43.9	19.1
Inventories, net	2,549.8	2,573.7
Deferred tax assets	159.5	133.1
Other assets	390.0	488.8
Total current assets	7,146.2	7,707.6

Finance receivables, net	55.3	124.0
Deferred tax assets	28.8	29.0
Other assets	444.8	450.9
Goodwill	2,357.5	2,624.6
Other intangible assets, net	723.8	738.2
Property, plant and equipment, net	1,447.5	1,620.7
Total non-current assets	5,057.7	5,587.4

Total assets	12,203.9	13,295.0

LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities	2,888.8	3,107.2

Long-term debt	1,149.9	1,125.5
Deferred and other tax liabilities	237.3	256.7
Provisions	3.6	2.4
Accrued and other liabilities	411.7	414.4
Total non-current liabilities	1,802.5	1,799.0

Total liabilities	4,691.3	4,906.2

Total shareholders’ equity	7,512.6	8,388.8
Total liabilities and shareholders’ equity	12,203.9	13,295.0

ASML - Summary US GAAP Consolidated Statements of Cash Flows^1,2



	Three months ended,				Twelve months ended,
	Dec 31,		Dec 31,		Dec 31,		Dec 31,
	2014		2015		2014		2015
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income	304.8		292.4		1,196.6		1,387.2

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	62.5		80.5		254.6		296.9
Impairment	0.5		1.5		10.5		2.3
Loss on disposal of property, plant and equipment	1.4		—		3.5		1.6
Share-based payments	13.1		14.7		63.4		59.1
Allowance for doubtful receivables	(0.2	)	1.2		0.1		3.9
Allowance for obsolete inventory	40.3		58.2		162.8		211.8
Deferred income taxes	(1.2	)	(2.8	)	(59.1	)	45.3
Changes in assets and liabilities	(12.0	)	539.0		(607.2	)	17.4
Net cash provided by (used in) operating activities	409.2		984.7		1,025.2		2,025.5

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(127.9	)	(120.5	)	(358.3	)	(371.8	)
Purchase of intangible assets	—		—		(3.0	)	(1.1	)
Purchase of available for sale securities	(25.0	)	(950.0	)	(504.7	)	(950.0	)
Maturity of available for sale securities	229.9		—		849.8		334.9
Cash from (used for) derivative financial instruments	—		(7.1	)	—		(171.9	)
Net cash provided by (used in) investing activities	77.0		(1,077.6	)	(16.2	)	(1,159.9	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid	—		—		(268.0	)	(302.3	)
Purchase of shares	(229.0	)	(140.7	)	(700.0	)	(564.9	)
Net proceeds from issuance of shares	15.5		9.7		39.7		33.2
Repayment of debt	(0.8	)	(1.1	)	(4.1	)	(3.6	)
Tax benefit from share-based payments	1.2		0.8		4.0		3.7
Net cash provided by (used in) financing activities	(213.1	)	(131.3	)	(928.4	)	(833.9	)

Net cash flows	273.1		(224.2	)	80.6		31.7

Effect of changes in exchange rates on cash	1.6		2.0		8.2		7.5
Net increase (decrease) in cash and cash equivalents	274.7		(222.2	)	88.8		39.2

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations ^1,2



	Three months ended,
		Dec 31,		Mar 29,		Jun 28,		Sep 27,		Dec 31,
		2014		2015		2015		2015		2015
(in millions EUR, except per share data)

Net system sales		1,085.3		1,246.5		1,134.5		975.3		880.9
Net service and field option sales		408.7		403.4		519.6		573.9		553.3
Total net sales		1,494.0		1,649.9		1,654.1		1,549.2		1,434.2

Total cost of sales		(837.1	)	(871.3	)	(900.3	)	(845.7	)	(774.4	)
Gross profit		656.9		778.6		753.8		703.5		659.8

Other income		20.2		20.8		20.8		20.8		20.8
Research and development costs		(268.0	)	(261.4	)	(267.4	)	(266.3	)	(273.0	)
Selling, general and administrative costs		(79.4	)	(82.3	)	(88.3	)	(85.6	)	(89.5	)
Income from operations		329.7		455.7		418.9		372.4		318.1

Interest and other, net		(2.6	)	(3.5	)	(4.2	)	(4.2	)	(4.6	)
Income before income taxes		327.1		452.2		414.7		368.2		313.5

Benefit from (provision for) income taxes		(22.3	)	(49.5	)	(45.0	)	(45.8	)	(21.1	)
Net income		304.8		402.7		369.7		322.4		292.4


Basic net income per ordinary share		0.70		0.93		0.86		0.75		0.68
Diluted net income per ordinary share	³	0.70		0.93		0.85		0.75		0.68


Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic		434.1		432.6		431.4		429.9		428.8
Diluted	³	436.7		435.3		433.8		432.3		430.8

ASML - Quarterly Summary Ratios and other data ^1,2




	Dec 31,		Mar 29,		Jun 28,			Sep 27,			Dec 31,
	2014		2015		2015			2015			2015
(in millions EUR, except otherwise indicated)

Gross profit as a percentage of net sales	44.0	%	47.2	%	45.6	%		45.4	%		46.0	%
Income from operations as a percentage of net sales	22.1	%	27.6	%	25.3	%		24.0	%		22.2	%
Net income as a percentage of net sales	20.4	%	24.4	%	22.4	%		20.8	%		20.4	%
Income taxes as a percentage of income before income taxes	6.8	%	11.0	%	10.8	%		12.4	%		6.7	%
Shareholders’ equity as a percentage of total assets	61.6	%	61.7	%	62.8	%		64.1	%		63.1	%
Sales of systems (in units)	35		47		41			44			37
Average selling price of system sales (EUR millions)	31.0		26.5		27.7			22.2			23.8
Value of systems backlog (EUR millions)	2,772		2,602		3,015		⁴	2,880		⁴	3,184		⁴
Systems backlog (in units)	82		75		81		⁴	72		⁴	79		⁴
Average selling price of systems backlog (EUR millions)	33.8		34.7		37.2		⁴	40.0		⁴	40.3		⁴
Value of booked systems (EUR millions)	1,387		1,028		1,523		⁴	904		⁴	1,184		⁴
Net bookings (in units)	51		40		46		⁴	35		⁴	44		⁴
Average selling price of booked systems (EUR millions)	27.2		25.7		33.1		⁴	25.8		⁴	26.9		⁴
Number of payroll employees in FTEs	11,318		11,533		11,676			11,920			12,168
Number of temporary employees in FTEs	2,754		2,644		2,527			2,498			2,513

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets^1,2



	Dec 31,	Mar 29,	Jun 28,	Sep 27,	Dec 31,
	2014	2015	2015	2015	2015
(in millions EUR)

ASSETS
Cash and cash equivalents	2,419.5	2,778.5	2,495.0	2,680.9	2,458.7
Short-term investments	334.9	60.0	25.0	—	950.0
Accounts receivable, net	1,052.5	1,270.6	1,282.3	1,089.4	803.7
Finance receivables, net	196.1	184.0	251.2	453.7	280.5
Current tax assets	43.9	94.3	52.3	42.8	19.1
Inventories, net	2,549.8	2,607.5	2,592.1	2,537.0	2,573.7
Deferred tax assets	159.5	173.8	178.1	127.6	133.1
Other assets	390.0	456.4	435.8	416.1	488.8
Total current assets	7,146.2	7,625.1	7,311.8	7,347.5	7,707.6

Finance receivables, net	55.3	55.3	55.7	49.8	124.0
Deferred tax assets	28.8	30.5	33.3	32.8	29.0
Other assets	444.8	472.2	435.0	429.4	450.9
Goodwill	2,357.5	2,610.8	2,569.4	2,574.0	2,624.6
Other intangible assets, net	723.8	773.8	751.2	739.5	738.2
Property, plant and equipment, net	1,447.5	1,523.4	1,518.9	1,532.6	1,620.7
Total non-current assets	5,057.7	5,466.0	5,363.5	5,358.1	5,587.4

Total assets	12,203.9	13,091.1	12,675.3	12,705.6	13,295.0

LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities	2,888.8	3,194.3	2,853.9	2,711.3	3,107.2

Long-term debt	1,149.9	1,155.5	1,115.8	1,125.3	1,125.5
Deferred and other tax liabilities	237.3	269.3	269.5	259.2	256.7
Provisions	3.6	3.7	3.2	2.8	2.4
Accrued and other liabilities	411.7	391.5	470.3	462.1	414.4
Total non-current liabilities	1,802.5	1,820.0	1,858.8	1,849.4	1,799.0

Total liabilities	4,691.3	5,014.3	4,712.7	4,560.7	4,906.2

Total shareholders’ equity	7,512.6	8,076.8	7,962.6	8,144.9	8,388.8
Total liabilities and shareholders’ equity	12,203.9	13,091.1	12,675.3	12,705.6	13,295.0

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows^1,2



	Three months ended,
		Dec 31,		Mar 29,		Jun 28,		Sep 27,		Dec 31,
		2014		2015		2015		2015		2015
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income		304.8		402.7		369.7		322.4		292.4

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		62.5		66.1		72.8		77.5		80.5
Impairment		0.5		—		0.6		0.2		1.5
Loss on disposal of property, plant and equipment		1.4		0.9		0.4		0.3		—
Share-based payments		13.1		14.6		15.0		14.8		14.7
Allowance for doubtful receivables		(0.2	)	0.4		1.7		0.6		1.2
Allowance for obsolete inventory		40.3		37.0		60.3		56.3		58.2
Deferred income taxes		(1.2	)	16.5		(9.4	)	41.0		(2.8	)
Changes in assets and liabilities		(12.0	)	(201.0	)	(227.3	)	(93.3	)	539.0
Net cash provided by (used in) operating activities		409.2		337.2		283.8		419.8		984.7

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(127.9	)	(85.6	)	(79.2	)	(86.5	)	(120.5	)
Purchase of intangible assets		—		(1.1	)	—		—		—
Purchase of available for sale securities		(25.0	)	—		—		—		(950.0	)
Maturity of available for sale securities		229.9		274.9		35.0		25.0		—
Cash from (used for) derivative financial instruments		—		(64.0	)	(63.0	)	(37.8	)	(7.1	)
Net cash provided by (used in) investing activities		77.0		124.2		(107.2	)	(99.3	)	(1,077.6	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		—		—		(302.3	)	—		—
Purchase of shares		(229.0	)	(117.1	)	(165.6	)	(141.5	)	(140.7	)
Net proceeds from issuance of shares		15.5		4.4		10.1		9.0		9.7
Repayment of debt		(0.8	)	(0.8	)	(0.7	)	(1.0	)	(1.1	)
Tax benefit from share-based payments		1.2		1.8		0.6		0.5		0.8
Net cash provided by (used in) financing activities		(213.1	)	(111.7	)	(457.9	)	(133.0	)	(131.3	)

Net cash flows		273.1		349.7		(281.3	)	187.5		(224.2	)

Effect of changes in exchange rates on cash		1.6		9.3		(2.2	)	(1.6	)	2.0
Net increase (decrease) in cash and cash equivalents		274.7		359.0		(283.5	)	185.9		(222.2	)

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of Presentation

The accompanying summary consolidated financial statements are stated in millions of euros ("EUR") unless otherwise indicated. ASML follows accounting principles generally accepted in the United States of America ("US GAAP"). Further disclosures, as required under US GAAP in annual reports, are not included in the summary consolidated financial statements.

Use of estimates

The preparation of our consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of net sales and costs during the reported periods. Actual results could differ from those estimates.

Principles of consolidation

The consolidated financial statements include the financial statements of ASML Holding N.V. and all of its subsidiaries and the variable interest entity of which ASML is the primary beneficiary (referred to as "ASML"). All intercompany profits, balances and transactions have been eliminated in the consolidation. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than 50 percent of the voting rights.

Revenue recognition

In general, we recognize revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in our cleanroom facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system's performance is re-tested upon installation at the customer's site, we have never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, such as NXE:3300B, we initially defer revenue recognition until acceptance of the new technology based system and completion of installation at the customer's premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely "new" technology occurs infrequently, and in the past 15 years, has occurred on only two occasions: 2000 (TWINSCAN) and 2010 (EUV).

The main portion of our revenue is derived from contractual arrangements with our customers that have multiple deliverables, which mainly include the sale of our systems, installation and training services and prepaid extended and enhanced (optic) warranty contracts. For each of the specified deliverables ASML determines the selling price by using either vendor specific objective evidence (‘VSOE’), third party evidence (‘TPE’) or by best estimate of the selling price (‘BESP’). When we are unable to establish relative selling price using VSOE or TPE, ASML uses BESP in its allocation of arrangement consideration. The total arrangement consideration is allocated at inception of the arrangement to all deliverables on the basis of their relative selling price. The revenue relating to the undelivered elements of the arrangements is deferred at their relative selling prices until delivery of these elements. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract.

For our NXE:3300B systems, we are unable to determine VSOE for prepaid extended, enhanced (optic) warranty contracts and installation. We determined for NXE:3300B systems that BESP is the appropriate reference in the fair value hierarchy for prepaid extended and enhanced (optic) warranty contracts. We review selling prices periodically and maintain internal controls over the establishment and updates of these elements.

Foreign currency risk management

Our sales are predominately denominated in euros. Exceptions may occur on a customer by customer basis. Our cost of sales and other expenses are mainly denominated in euros, to a certain extent in U.S. dollars, Taiwanese dollars and Japanese yen and to a limited extent in other currencies. Therefore, we are exposed to foreign currency exchange risks.

It is our policy to hedge material transaction exposures, such as forecasted sales and purchase transactions, and material net remeasurement exposures, such as accounts receivable and payable. We hedge these exposures through the use of foreign exchange contracts.

ASML – Reconciliation US GAAP – IFRS ^1,2



Net income	Three months ended,				Twelve months ended,
	Dec 31,		Dec 31,		Dec 31,	Dec 31,
	2014		2015		2014	2015
(in millions EUR)
Net income based on US GAAP	304.8		292.4		1,196.6	1,387.2
Development expenditures (see Note 1)	83.6		55.0		194.3	244.7
Share-based payments (see Note 2)	0.9		(0.3	)	5.0	2.1
Income taxes (see Note 3)	(4.3	)	(2.8	)	22.4	(14.5	)
Net income based on IFRS	385.0		344.3		1,418.3	1,619.5



Shareholders' equity	Dec 31,	Mar 29,	Jun 28,	Sep 27,	Dec 31,
	2014	2015	2015	2015	2015
(in millions EUR)
Shareholders' equity based on US GAAP	7,512.6	8,076.8	7,962.6	8,144.9	8,388.8
Development expenditures (see Note 1)	792.1	878.1	937.9	995.7	1,054.5
Share-based payments (see Note 2)	21.0	22.4	22.0	18.3	16.5
Income taxes (see Note 3)	40.2	42.1	29.1	32.9	31.4
Equity based on IFRS	8,365.9	9,019.4	8,951.6	9,191.8	9,491.2

Notes to the reconciliation from US GAAP to IFRS

Note 1 Development expenditures

Under US GAAP, ASML applies ASC 730, "Research and Development". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Under IFRS, ASML applies IAS 38, "Intangible Assets". In accordance with IAS 38, ASML capitalizes certain development expenditures that are amortized over the expected useful life of the related product generally ranging between one and five years. Amortization starts when the developed product is ready for volume production.

Note 2 Share-based Payments

Under US GAAP, ASML applies ASC 718 "Compensation - Stock Compensation" which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as we recognize compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under US GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in ASML’s share price do not affect the deferred tax asset recorded in our financial statements.

Under IFRS, ASML applies IFRS 2, "Share-based Payments". In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and shares granted to its employees. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in ASML’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

Note 3 Income taxes

Under US GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under US GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

Under IFRS, ASML applies IAS 12, "Income Taxes". In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.


¹	These financial statements are unaudited.


²	Numbers have been rounded.

The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.


⁴	As of Q2 2015, our systems backlog and net bookings include all system sales orders for which written authorizations have been accepted (for EUV starting as of the NXE:3350B). This change has no impact on the comparative figures.

Exhibit 99.4

ASML - Summary IFRS Consolidated Statement of Profit or Loss ^1,2



	Three months ended,				Twelve months ended,
	Dec 31,		Dec 31,		Dec 31,		Dec 31,
	2014		2015		2014		2015
(in millions EUR)

Net system sales	1,085.3		880.9		4,242.8		4,237.2
Net service and field option sales	408.7		553.3		1,613.5		2,050.2
Total net sales	1,494.0		1,434.2		5,856.3		6,287.4

Total cost of sales	(854.9	)	(792.2	)	(3,358.9	)	(3,454.3	)
Gross profit	639.1		642.0		2,497.4		2,833.1

Other income	20.2		20.8		81.0		83.2
Research and development costs	(149.8	)	(189.8	)	(735.9	)	(710.2	)
Selling, general and administrative costs	(78.9	)	(89.5	)	(318.7	)	(345.3	)
Operating income	430.6		383.5		1,523.8		1,860.8

Interest and other, net	1.9		1.6		2.6		(4.7	)
Income before income taxes	432.5		385.1		1,526.4		1,856.1

Benefit from (provision for) income taxes	(47.5	)	(40.8	)	(108.1	)	(236.6	)
Net income	385.0		344.3		1,418.3		1,619.5

ASML - Summary IFRS Consolidated Statement of Financial Position ^1,2



	Dec 31,	Dec 31,
	2014	2015
(in millions EUR)

ASSETS
Property, plant and equipment	1,447.5	1,620.7
Goodwill	2,378.4	2,647.8
Other intangible assets	1,670.1	2,018.5
Deferred tax assets	142.7	139.6
Finance receivables	55.3	124.0
Derivative financial instruments	115.5	81.8
Other assets	329.3	369.1
Total non-current assets	6,138.8	7,001.5

Inventories	2,549.8	2,573.7
Current tax assets	43.9	19.1
Derivative financial instruments	38.3	52.0
Finance receivables	196.1	280.5
Accounts receivable	1,052.5	803.7
Other assets	293.6	375.6
Short-term investments	334.9	950.0
Cash and cash equivalents	2,419.5	2,458.7
Total current assets	6,928.6	7,513.3

Total assets	13,067.4	14,514.8

EQUITY AND LIABILITIES
Equity	8,365.9	9,491.2

Long-term debt	1,149.9	1,125.5
Derivative financial instruments	2.8	1.9
Deferred and other tax liabilities	249.3	376.5
Provisions	3.6	2.4
Accrued and other liabilities	408.9	412.5
Total non-current liabilities	1,814.5	1,918.8

Provisions	2.4	2.4
Derivative financial instruments	64.9	19.0
Current portion of long-term debt	4.3	4.2
Current and other tax liabilities	36.3	3.7
Accrued and other liabilities	2,282.9	2,656.6
Accounts payable	496.2	418.9
Total current liabilities	2,887.0	3,104.8

Total equity and liabilities	13,067.4	14,514.8

ASML - Summary IFRS Consolidated Statement of Cash Flows ^1,2



	Three months ended,				Twelve months ended,
	Dec 31,		Dec 31,		Dec 31,		Dec 31,
	2014		2015		2014		2015
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income	385.0		344.3		1,418.3		1,619.5

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	80.1		98.4		353.1		359.9
Impairment	0.5		1.5		10.5		2.3
Loss on disposal of property, plant and equipment	1.4		—		3.5		1.6
Share-based payments	12.3		12.6		55.7		50.1
Allowance for doubtful receivables	(0.2	)	1.2		0.1		3.9
Allowance for obsolete inventory	40.3		58.2		162.8		211.8
Deferred income taxes	33.3		20.5		(30.1	)	134.8
Changes in assets and liabilities	(21.5	)	537.8		(599.6	)	15.6
Net cash provided by (used in) operating activities	531.2		1,074.5		1,374.3		2,399.5

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(127.9	)	(120.5	)	(358.3	)	(371.8	)
Purchase of intangible assets	(120.8	)	(89.0	)	(348.1	)	(371.4	)
Purchase of available for sale securities	(25.0	)	(950.0	)	(504.7	)	(950.0	)
Maturity of available for sale securities	229.9		—		849.8		334.9
Cash from (used for) derivative financial instruments	—		(7.1	)	—		(171.9	)
Net cash provided by (used in) investing activities	(43.8	)	(1,166.6	)	(361.3	)	(1,530.2	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid	—		—		(268.0	)	(302.3	)
Purchase of shares	(229.0	)	(140.7	)	(700.0	)	(564.9	)
Net proceeds from issuance of shares	15.5		9.7		39.7		33.2
Repayment of debt	(0.8	)	(1.1	)	(4.1	)	(3.6	)
Net cash provided by (used in) financing activities	(214.3	)	(132.1	)	(932.4	)	(837.6	)

Net cash flows	273.1		(224.2	)	80.6		31.7

Effect of changes in exchange rates on cash	1.6		2.0		8.2		7.5
Net increase (decrease) in cash and cash equivalents	274.7		(222.2	)	88.8		39.2

ASML - Quarterly Summary IFRS Consolidated Statement of Profit or Loss ^1,2



	Three months ended,
		Dec 31,		Mar 29,		Jun 28,		Sep 27,		Dec 31,
		2014		2015		2015		2015		2015
(in millions EUR)

Net system sales		1,085.3		1,246.5		1,134.5		975.3		880.9
Net service and field option sales		408.7		403.4		519.6		573.9		553.3
Total net sales		1,494.0		1,649.9		1,654.1		1,549.2		1,434.2

Total cost of sales		(854.9	)	(885.4	)	(916.7	)	(860.0	)	(792.2	)
Gross profit		639.1		764.5		737.4		689.2		642.0

Other income		20.2		20.8		20.8		20.8		20.8
Research and development costs		(149.8	)	(164.1	)	(176.8	)	(179.5	)	(189.8	)
Selling, general and administrative costs		(78.9	)	(82.7	)	(87.9	)	(85.2	)	(89.5	)
Operating income		430.6		538.5		493.5		445.3		383.5

Interest and other, net		1.9		(0.9	)	(1.1	)	(4.3	)	1.6
Income before income taxes		432.5		537.6		492.4		441.0		385.1

Benefit from (provision for) income taxes		(47.5	)	(67.6	)	(71.1	)	(57.1	)	(40.8	)
Net income		385.0		470.0		421.3		383.9		344.3

ASML - Quarterly Summary IFRS Consolidated Statement of Financial Position^1,2



	Dec 31,	Mar 29,	Jun 28,	Sep 27,	Dec 31,
	2014	2015	2015	2015	2015
(in millions EUR)

ASSETS
Property, plant and equipment	1,447.5	1,523.4	1,518.9	1,532.6	1,620.7
Goodwill	2,378.4	2,633.9	2,592.2	2,596.8	2,647.8
Other intangible assets	1,670.1	1,831.4	1,881.9	1,942.7	2,018.5
Deferred tax assets	142.7	151.5	146.8	147.2	139.6
Finance receivables	55.3	55.3	55.7	49.8	124.0
Derivative financial instruments	115.5	130.3	87.0	82.9	81.8
Other assets	329.3	342.0	348.0	346.5	369.1
Total non-current assets	6,138.8	6,667.8	6,630.5	6,698.5	7,001.5

Inventories	2,549.8	2,607.5	2,592.1	2,537.0	2,573.7
Current tax assets	43.9	94.3	52.3	42.8	19.1
Derivative financial instruments	38.3	41.1	51.0	52.1	52.0
Finance receivables	196.1	184.0	251.2	453.7	280.5
Accounts receivable	1,052.5	1,270.6	1,282.3	1,089.4	803.7
Other assets	293.6	353.8	320.4	302.7	375.6
Short-term investments	334.9	60.0	25.0	—	950.0
Cash and cash equivalents	2,419.5	2,778.5	2,495.0	2,680.9	2,458.7
Total current assets	6,928.6	7,389.8	7,069.3	7,158.6	7,513.3

Total assets	13,067.4	14,057.6	13,699.8	13,857.1	14,514.8

EQUITY AND LIABILITIES
Equity	8,365.9	9,019.4	8,951.6	9,191.8	9,491.2

Long-term debt	1,149.9	1,155.5	1,115.8	1,125.3	1,125.5
Derivative financial instruments	2.8	2.6	2.3	2.1	1.9
Deferred and other tax liabilities	249.3	295.3	305.2	363.9	376.5
Provisions	3.6	3.7	3.2	2.8	2.4
Accrued and other liabilities	408.9	388.9	468.0	460.0	412.5
Total non-current liabilities	1,814.5	1,846.0	1,894.5	1,954.1	1,918.8

Provisions	2.4	2.4	2.4	2.4	2.4
Derivative financial instruments	64.9	118.4	38.1	18.4	19.0
Current portion of long-term debt	4.3	4.3	4.2	4.2	4.2
Current and other tax liabilities	36.3	32.4	18.1	1.6	3.7
Accrued and other liabilities	2,282.9	2,299.4	2,069.2	2,180.8	2,656.6
Accounts payable	496.2	735.3	721.7	503.8	418.9
Total current liabilities	2,887.0	3,192.2	2,853.7	2,711.2	3,104.8

Total equity and liabilities	13,067.4	14,057.6	13,699.8	13,857.1	14,514.8

ASML - Quarterly Summary IFRS Consolidated Statement of Cash Flows ^1,2



	Three months ended,
		Dec 31,		Mar 29,		Jun 28,		Sep 27,		Dec 31,
		2014		2015		2015		2015		2015
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income		385.0		470.0		421.3		383.9		344.3

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		80.1		80.3		89.3		91.9		98.4
Impairment		0.5		—		0.6		0.2		1.5
Loss on disposal of property, plant and equipment		1.4		0.9		0.4		0.3		—
Share-based payments		12.3		13.4		14.2		9.9		12.6
Allowance for doubtful receivables		(0.2	)	0.4		1.7		0.6		1.2
Allowance for obsolete inventory		40.3		37.0		60.3		56.3		58.2
Deferred income taxes		33.3		40.1		14.8		59.4		20.5
Changes in assets and liabilities		(21.5	)	(202.6	)	(223.8	)	(95.8	)	537.8
Net cash provided by (used in) operating activities		531.2		439.5		378.8		506.7		1,074.5

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(127.9	)	(85.6	)	(79.2	)	(86.5	)	(120.5	)
Purchase of intangible assets		(120.8	)	(101.6	)	(94.4	)	(86.4	)	(89.0	)
Purchase of available for sale securities		(25.0	)	—		—		—		(950.0	)
Maturity of available for sale securities		229.9		274.9		35.0		25.0		—
Cash from (used for) derivative financial instruments		—		(64.0	)	(63.0	)	(37.8	)	(7.1	)
Net cash provided by (used in) investing activities		(43.8	)	23.7		(201.6	)	(185.7	)	(1,166.6	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		—		—		(302.3	)	—		—
Purchase of shares		(229.0	)	(117.1	)	(165.6	)	(141.5	)	(140.7	)
Net proceeds from issuance of shares		15.5		4.4		10.1		9.0		9.7
Repayment of debt		(0.8	)	(0.8	)	(0.7	)	(1.0	)	(1.1	)
Net cash provided by (used in) financing activities		(214.3	)	(113.5	)	(458.5	)	(133.5	)	(132.1	)

Net cash flows		273.1		349.7		(281.3	)	187.5		(224.2	)

Effect of changes in exchange rates on cash		1.6		9.3		(2.2	)	(1.6	)	2.0
Net increase (decrease) in cash and cash equivalents		274.7		359.0		(283.5	)	185.9		(222.2	)

Notes to the Summary IFRS Consolidated Financial Statements

Basis of Presentation

The accompanying summary consolidated financial statements are stated in millions of euros ("EUR") unless otherwise indicated.

ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards as adopted by the EU (“IFRS”) accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included in the summary consolidated financial statements.

For internal and external reporting purposes, we apply accounting principles generally accepted in the United States of America ("US GAAP"). US GAAP is our primary accounting standard for the setting of financial and operational performance targets.

Use of estimates

The preparation of our consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of net sales and costs during the reported periods. Actual results could differ from those estimates.

Basis of consolidation

The consolidated financial statements include the financial statements of ASML Holding N.V. and all of its subsidiaries and the special purpose entity of which ASML is the primary beneficiary (referred to as "ASML"). All intercompany profits, balances and transactions have been eliminated in the consolidation. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than 50 percent of the voting rights.

Revenue recognition

In general, we recognize the revenue from the sale of a system upon shipment and the revenue from the installation of a system upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in our cleanroom facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system's performance is re-tested upon installation at the customer's site, we have never failed to successfully complete installation of a system at a customer’s premises.

Foreign currency risk management

ASML – Reconciliation US GAAP – IFRS ^1,2



Net income	Three months ended,				Twelve months ended,
	Dec 31,		Dec 31,		Dec 31,	Dec 31,
	2014		2015		2014	2015
(in millions EUR)
Net income based on US GAAP	304.8		292.4		1,196.6	1,387.2
Development expenditures (see Note 1)	83.6		55.0		194.3	244.7
Share-based payments (see Note 2)	0.9		(0.3	)	5.0	2.1
Income taxes (see Note 3)	(4.3	)	(2.8	)	22.4	(14.5	)
Net income based on IFRS	385.0		344.3		1,418.3	1,619.5



Shareholders' equity	Dec 31,	Mar 29,	Jun 28,	Sep 27,	Dec 31,
	2014	2015	2015	2015	2015
(in millions EUR)
Shareholders' equity based on US GAAP	7,512.6	8,076.8	7,962.6	8,144.9	8,388.8
Development expenditures (see Note 1)	792.1	878.1	937.9	995.7	1,054.5
Share-based payments (see Note 2)	21.0	22.4	22.0	18.3	16.5
Income taxes (see Note 3)	40.2	42.1	29.1	32.9	31.4
Equity based on IFRS	8,365.9	9,019.4	8,951.6	9,191.8	9,491.2

Notes to the reconciliation from US GAAP to IFRS

Note 1 Development expenditures

Under US GAAP, ASML applies ASC 730, "Research and Development". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 2 Share-based Payments

Note 3 Income taxes


¹	These financial statements are unaudited.


²	Numbers have been rounded.

ASML Holding NV (NASDAQ:ASML)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more ASML Holding NV Charts.

ASML Holding NV (NASDAQ:ASML)
Historical Stock Chart
From Apr 2023 to Apr 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ASML ASML Holding NV

Latest ASML Messages

Loading Messages....

Asml Holding Nv News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ASML ASML Holding NV

Latest ASML Messages

Loading Messages....

Asml Holding Nv News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App